Serfaty, Marc
Satchell, Jessica
Laycock, Gloria K.
Brewin, Chris R.
Buszewicz, Marta
Leavey, Gerard
Drennan, Vari M.
Cooke, Jonathan
Kessel, Anthony
Funding for this research was provided by:
PHR-NIHR (13/164/32)
UCLH Biomedical Research Centre
Article History
Received: 1 May 2024
Accepted: 3 December 2024
First Online: 15 January 2025
Declarations
:
: The VIP trial was registered with the University Data Protection Office on the 26th February 2016. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human participants were approved by the UCL Research Ethics Committee on the 17th March 2016 (6960/001). Signed informed consent was obtained for all participants. The International Standard Randomised Controlled Trial Number is ISRCTN16929670: .
: All the authors in this paper consented to publication. We have purposefully maintained anonymity of the services involved in this work.
: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.